Библиография
- Berthelot J, Centonze M. Etude controlee
en double aveugle Duspatalin (mebeverine) contre placebo, dans
Ie traitement du colon irritable. Gaz Med Fr 1981; 88/16: 2341-2343
- Boisson J, Coudert Ph et al. Tolerance de
la mebeverine a long terme. Act Ther 1987; 16: 289-292
- Cann PA. How to assess the effectiveness
of a therapy in irritable bowel syndrome (IBS). In "Calcium Antagonism
in Gastrointestinal Motility" Ed. Christen Т et al, Pub. Elsevier,
1989: 43-48
- Connell AM. Physiological and clinical assessment
of the effect of the musculotropic agent mebeverine on the human
colon. Br MedJ 1965; 2: 848-851
- Daly J, Bergin A, Sun WM, Read NW. Effect
of food and anti-cholinergic drugs on the pattern of rectosigmoid
contractions. Gut 1993; 34: 799-802
- Delaunay P, Veron M. Colopathies fonctionnelles
des sujets ages: efficacite et tolerance d'une nouvelle forme
galenique. Gaz Med 1986; 93: 102-106
- Delvaux M, Ribet A. Etude de I'efficacite,
de I'innocuite et de la tolerance de Duspatalin® 200mg gelules
chez des patients presentant des troubles fonctionnels du tractus
gastro-intestinal (colopathie fonctionelle). Abstract Gastro 1994;
84: 2-3
- Dickinson RG. Facile hydrolysis of mebeverine
in vitro and in vivo: negligible circulation concentrations of
the drug after oral administration. J Pharm Sci 1991; 80: 952-957
- Estrada A, de Azevedo V. Ensaio de um novo
medicamento na dor abdominal recorrente, em pediatria. Med Policlin
1985; 146: 21-28
- Evans PR, Bak Y-T, Kellow JE. Mebeverine
alters small bowel motility in irritable bowel syndrome. Aliment
Pharmakol Ther 1996; 10: 787-793
- Fletcher СР. Clinical experience with mebeverine
200 mg. Data of File, Solvay 1997.
- Le Gal M, Peloux Ch. Colopathie fonctionnelle.
Impact Medecin 1989; 3 Juin: 2-4
- Gilly R. Douleurs abdominales fonctionnelles
de I'enfant. Med enfance 1989; March: 159-162
- Grillage MG, Nankani JN et al. A randomised,
double-blind study of mebeverine versus dicyclomine in the treatment
of functional abdominal pain in young adults. Br J Clin Pract
1990; 44: 176-179
- Guyot P, and a General Practitioner Group
of the General Practitioners' Research Association. Efficacy of
"Duspatalin" 200mg in patients with irritable bowel syndrom. Results
of a descriptive study on various symptom subgroups. Act Med Int-Gastroenterologie
1997; 11: 2-7
- Den Hertog A, Van den Akker J. Modification
of к,-receptor-operated channels by mebeverine in smooth muscle
cells of guinea-pig taenia caeci. Eur J Pharmacol 1987; 138: 367-374
- Den Hertog A, Van den Akker J. The action
of mebeverine and metabolites on mammalian non-myelinated nerve
fibres. Eur J Pharmacol 1987; 139: 353-355
- Inauen W, Halter F. Clinical efficacy, safety
and tolerance of mebeverine prolonged release (200mg) vs mebeverine
tablets in patients with irritable bowel syndrome. Drug Invest
1994; 8 (4): 234-240
- Kastein E. Report on the safety and tolerance
of mebeverine 810mg daily dose. Data on File, Solvay, 1988.
- Parks TG. Colonic motility in man. Postgrad
MedJ 1973; 49: 90-99
- Poynard Т, Naveau S, Могу В, Chaput JC.
Meta-analysis of smooth muscle relaxants in the treatment of irritable
bowel syndrome. Aliment Pharmacol Ther 1994; 8: 499-510
- Prout BJ. The treatment of irritable bowel
syndrome: two doses of mebeverine compared. Lancet 1975; ii: 1260
- Salandre D, Mignon M. Efficacite comparee
de la fenoverine et de la mebeverine chez 192 patients attients
de troubles fonctionnels intestinaux. Gaz Med 1989; 96: 62-67
- SeccoGB, Di Somma С et al. Studio clinico
controllato sulla azione del cloridrato di mebeverina nel trattamento
del colon irritabile. Min Med 1983;p 74: 699-702
- Tasman-Jones С. Mebeverine in patients with
the irritable colon syndrome: double blind study. N Z Med J 1973;
77: 232-235
- Tudor GJ. A general practice study to compare
alverine citrate with mebeverine hydrochloride in the treatment
of irritable bowel syndrome. Br J Clin Pract 1986; 40: 276-278
- Van Outryve M, Mayeur S, Meeus MA, Rosillon
D, Hendrickx B, Ceuppens M. A double-blind crossover comparison
study of the safety and efficacy of mebeverine with mebeverine
sustained release in the treatment of irritable bowel syndrome.
J Clin Pharm Ther 1995; 20: 277-28
|
